NEW YORK, June 27, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 <\/p>\n
http:\/\/www.reportlinker.com\/p0829625\/Clinical-Chemistry-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics<\/a> <\/p>\n Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 <\/p>\n This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. <\/p>\n The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or oldera population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase. <\/p>\n - Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the six market categories. Data from 2003 to 2010, forecast forward for seven years to 2017. <\/p>\n - 2010 company shares and distribution shares data for the overall Clinical Chemistry market in each of the aforementioned countries. <\/p>\n - Global corporate-level profiles of key companies operating within the Clinical Chemistry market in BRICS. <\/p>\n - Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., Abbott Laboratories, Shanghai Kehua Bio-engineering Co., Ltd., Mindray Medical International Limited, Transasia Bio-Medicals Ltd. and Sysmex Corporation. <\/p>\n<\/p>\n Continue reading here: NEW YORK, June 27, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 http:\/\/www.reportlinker.com\/p0829625\/Clinical-Chemistry-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics<\/a> Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. Continue reading
\nClinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"